I reckon they'll be back to 2c in no time unless huge pre-order numbers come in through amazon, which is as likely as roame ever hitting the shelves Looks like all those director options will be worthless by the time they're approved at the next AGM
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status
